Metraipolis › archive › dc_3bab79ec6fb8
Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025 — Europe PMC PMID:41754598
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41754598
- DOI
- 10.3390/v18020255
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T15:59:30.465Z
- SHA-256 of the archived text
c82df95b41f5fff0282f90a350239f18f91a335a275c86af1669a7cf538746b7- Stable URL of this page
https://metraipolis.com/documento/dc_3bab79ec6fb8
How to cite
Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025 — Europe PMC PMID:41754598 — Europe PMC (en), https://europepmc.org/article/MED/41754598 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3bab79ec6fb8 (Metraipolis archive dc_3bab79ec6fb8, sha256 c82df95b41f5fff0282f90a350239f18f91a335a275c86af1669a7cf538746b7)
BibTeX
@misc{dc3bab79ec6fb8,
title = {Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025 — Europe PMC PMID:41754598},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41754598},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3bab79ec6fb8; sha256 c82df95b41f5fff0282f90a350239f18f91a335a275c86af1669a7cf538746b7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754598. Agents can read the archived copy with the MCP tool read_document.